参考文献/References:
[1]Littnerova S,Kala P,Jarkovsky J,et al.GRACE score among six risk scoring systems(CADILLAC,PAMI,TIMI,Dynamic TIMI,Zwolle)demonstrated the best predictive value for prediction of long-term mortality in patients with ST-elevation myocardial infarction[J].PLoS One,2015,10(4):e0123215.
[2]Fox KA,FitzGerald G,Puymirat E,et al.Should patients with acute coronary disease be stratified for management according to their risk?Derivation,external validation and outcomes using the updated GRACE risk score[J].BMJ Open,2014,4(2):e004425.
[3]Kozieradzka A,Kamiński KA,Maciorkowska D,et al.GRACE,TIMI,Zwolle and CADILLAC risk scores-Do they predict 5-year outcomes after ST-elevation myocardial infarction treated invasively?[J].Int J Cardiol,2011,148(1):70-75.
[4]Filipiak KJ,Koltowski L,Grabowski M,et al.Comparison of the seven-year predictive value of six risk scores in acute coronary syndrome patients:GRACE,TIMI STEMI,TIMI NSTEMI,SIMPLE,ZWOLLE and BANACH[J].Kardiol Pol,2014 72(2):155-165.
[5]D’Ascenzo F,Biondi-Zoccai G,Moretti C,et al.TIMI,GRACE and alternative risk scores in acute coronary syndromes:A meta-analysis of 40 derivation studies on 216552 patients and of 42 validation studies on 31625 patients[J].Contemp Clin Trials,2012,33(3):507-514.
[6]Antman EM,Cohen M,Bernink PJ,et al.The TIMI risk score for unstable angina/non-ST elevation MI:a method for prognostication and therapeutic decision making[J].JAMA,2000,284(1):835-842.
[7]Cook NR.Use and misuse of the receiver operating characteristic curve in risk prediction[J].Circulation,2007,115(7):928-935.
[8]Goodman SG,Huang W,Yan AT,et al.The expanded Global Registry of Acute Coronary Events:baseline characteristics,management practices,and hospital outcomes of patients with acute coronary syndromes[J].Am Heart J,2009,158(2): 193-201.
[9]Eagle KA,Lim MJ,Dabbous,OH,et al.A validated prediction model for all forms of acute coronary syndrome:estimating the risk of 6-month postdischarge death in an international registry[J].JAMA,2004,291(8):2727-2733.
[10]Simms AD,Reynolds S,Pieper K,et al.Evaluation of the NICE mini-GRACE risk scores for acute myocardial infarction using the Myocardial Ischaemia National Institute for Cardiovascular Outcomes Research(NICOR)[J].Heart,2013,99(1):35-40.
[11]Huang W,FitzGerald G,Goldberg RJ,et al.Performance of the GRACE risk score 2.0 simplified algorithm for predicting 1-year death following hospitalization for an acute coronary syndrome in a contemporary multiracial cohort[J].Am J Cardiol,2016, 118(8):1105-1110.
[12]Yan SD,Liu XJ,Peng Y,et al.Admission serum calcium levels improve the GRACE risk score prediction of hospital mortality in patients with acute coronary syndrome[J].Clin Cardiol,2016,39(9):516-523.
[13]Meune C,Drexler B,Haaf P,et al.The GRACE score’s performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptide[J].Heart,2011,97(18):1479-1483.
[14]Schellings DA,Adiyaman A,Dambrink JE,et al.Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes:a comparison with the GRACE and TIMI risk scores[J].Vasc Health Risk Manag,2016, 12(12):471-476.
[15]Fu R,Song CX,Yang JG,et al.CAMI-NSTEMI score-China Acute Myocardial Infarction Registry-derived novel tool to predict in-hospital death in non-ST segment elevation myocardial infarction patients[J].Circ J,2018,82(7):1884-1891.
[16]Xu HY, Li W , Yang JG , et al. The China Acute Myocardial Infarction (CAMI) Registry: A national long-term registry-research-education integrated platform for exploring acute myocardial infarction in China[J]. Am Heart J, 2016, 175(3):193-201.
[17]Peng Y,Du X,Rogers KD,et al.Predicting in-hospital mortality in patients with acute coronary syndrome in China[J].Am J Cardiol,2017,120(7):1077-1083.
[18]Sakamoto JT,Liu N,Koh ZX,et al.Comparing HEART,TIMI,and GRACE scores for prediction of 30-day major adverse cardiac events in high acuity chest pain patients in the emergency department[J].Int J Cardiol,2016,221(15): 759-764.
[19]Wei XB,Liu,YH,He PC,et al.Additive prognostic value of left ventricular ejection fraction to the TIMI risk score for in-hospital and long-term mortality in patients with ST segment elevation myocardial infarction[J].J Thromb Thrombolysis,2017, 43(1):1-6.
[20]Popovic B,Girerd N,Rossignol P,et al.Prognostic value of the thrombolysis in myocardial infarction risk score in ST-elevation myocardial infarction patients with left ventricular dysfunction(from the EPHESUS trial)[J].Am J Cardiol,2016,118(10): 1442-1447.
[21]Morrow DA,Antman EM,Parsons L,et al.Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3[J].JAMA,2001, 286(1):1356-1359.
[22]Song CX,Dou KF,Yang JG,et al.The CAMI-score:a novel tool derived from CAMI registry to predict in-hospital death among acute myocardial infarction patients[J]. Sci rep,2018,8(1):9082.
[23]Chalikias G,Serif L,Kikas P,et al.Long-term impact of acute kidney injury on prognosis in patients with acute myocardial infarction[J].Int J Cardiol,2019, 283(15): 48-54.
[24]Wang JY,Goodman SG,Saltzman I,et al.Cardiovascular risk factors and in-hospital mortality in acute coronary syndromes:insights from the Canadian Global Registry of Acute Coronary Events[J].Can J Cardiol,2015,31(12):1455-1461.
[25]Filipiak KJ,Koltowski L,Grabowski M,et al.Prospective comparison of the 5 most popular risk scores in clinical use for unselected patients with acute coronary syndrome:basis for design of the Banach score[J].Circ J,2011,75(1):167-173.
[26]Gong IY,Goodman SG,Brieger D,et al.GRACE risk score:sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome[J].Int J Cardiol,2017,244 (1):24-29.
[27]Allahwala UK,Tang J,Murphy JC,et al.Thrombolysis in myocardial infarction(TIMI) risk score and gender in the era of primary PCI-is there a difference?[J].Int J Cardiol,2012,161(2):117-118.
[28]Aggarwal NR,Patel HN,Mehta LS,et al. Sex?differences?in?ischemic?heart?disease?advances,?obstacles, and?next?steps[J]. Circ Cardiovasc Qual Outcomes,2018,11(2):e004437.
[29]Méndez-Eirín E,Flores-Ríos X,García-López F,et al.Comparison of the prognostic predictive value of the TIMI,PAMI,CADILLAC,and GRACE risk scores in STEACS undergoing primary or rescue PCI[J].Rev Esp Cardiol,2012, 65(3): 227-233.
[30]Brkovic V,Dobric M,Beleslin B,et al.Addictive prognostic value of the SYNTAX score over GRACE,TIMI,ZWOLLE,CADILLAC and PAMI risk scores in patients with acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention[J].Int J Cardiovasc Imaging,2013,29(6): 1215-1228.
[31]Sharkawi MA,Filippaios A,Dani SS,et al.Identifying patients for safe early hospital discharge following ST elevation myocardial infarction[J].Catheter Cardiovasc Interv,2017,89(7):1141-1146.
[32]Abelin AP,David RB,Gottschall CA,et al.Accuracy of dedicated risk scores in patients undergoing primary percutaneous coronary intervention in daily clinical practice[J].Can J Cardiol,2014,30(1):125-131.
[33]Schellings DA,Adiyaman A,Giannitsis E,et al.Early discharge after primary percutaneous coronary intervention:the added value of N-terminal pro-brain natriuretic peptide to the Zwolle risk score[J].J Am Heart Assoc,2014,3(6):e001089.
[34]Ganovska E,Arrigo M,Helanova K,et al.Natriuretic peptide in addition to Zwolle score to enhance safe and early discharge after acute myocardial infarction:a prospective observational cohort study[J].Int J Cardiol,2016,215(15): 527-531.
[35]Kul S,Uyarel H,Turfan M,et al.A new prognostic evaluation of patients with acute ST-elevation myocardial infarction undergoing primary angioplasty:combined Zwolle and Syntax score[J].Kardiol Pol,2014,72(2):146-154.
[36]Kul S,Uyarel H,Kucukdagli OT,et al.Zwolle risk score predicts contrast-induced acute kidney injury in STEMI patients undergoing PCI[J].Herz,2015,40(1):109-115.
[37]Zafrir B,Adawi S,Khalaily M,et al.Long-term risk stratification of patients undergoing coronary angiography according to the thrombolysis in myocardial infarction risk score for secondary prevention[J].J Am Heart Assoc,2019,8(14): e012433.
[38]Zhao QH,Yang YJ,Chen ZJ,et al.Changes in characteristics,risk factors,and in-hospital mortality among patients with acute myocardial infarction in the capital of China over 40 years[J].Int J Cardiol,2018,265(15):30-34.
[39]Mcnamara RL, Kennedy KF, Cohen DJ,et al. Predicting in-hospital mortality in patients?with acute myocardial infarction[J]. J Am Coll Cardiol, 2016, 68(6):626-635.
相似文献/References:
[1]李润土,何泉.光学相干断层成像在急性冠脉综合征介入治疗中的应用[J].心血管病学进展,2019,(6):856.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.005]
LI Runtu,HE Quan.Application of Optical Coherent Tomography in Interventional Treatment of Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(9):856.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.005]
[2]郑晓雪 季福绥.急性冠脉综合征患者发生急性肾损伤的临床进展[J].心血管病学进展,2019,(5):713.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.013]
ZHENG Xiaoxue,JI Fusui.Acute Kidney Injury in Patients with Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(9):713.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.013]
[3]周小琳 何泉.替格瑞洛在急性冠脉综合征合并慢性肾脏病患者中的应用研究进展[J].心血管病学进展,2019,(5):718.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.014]
ZHOU Xiaolin,HE Quan.Ticagrelor in Acute Coronary Syndrome with Chronic Kidney Disease[J].Advances in Cardiovascular Diseases,2019,(9):718.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.014]
[4]吕颖 胡思宁 于波 贾海波.斑块侵蚀发病机制的最新研究进展[J].心血管病学进展,2020,(1):74.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.020]
LU Ying,HU Sining,YU Bo,et al.Pathogenic Mechanisms of Plaque Erosion[J].Advances in Cardiovascular Diseases,2020,(9):74.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.020]
[5]段继坤,林志,杨帆,等.斑块侵蚀引起的急性冠脉综合征的研究新进展[J].心血管病学进展,2020,(3):281.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.016]
DUAN Jikun,LIN Zhi,YANG Fan,et al.Acute Coronary Syndrome Caused by Plaque Erosion[J].Advances in Cardiovascular Diseases,2020,(9):281.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.016]
[6]陈凯磊 胡闻竹 苏冠华.P2Y12抑制剂与癌症风险的相关性研究进展[J].心血管病学进展,2020,(8):798.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.004]
CHEN Kailei,HU Wenzhu,SU Guanhua.Advances in Studies on the Correlation between P2Y12 Inhibitors and Cancer Risk[J].Advances in Cardiovascular Diseases,2020,(9):798.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.004]
[7]肖雨尘 赵仙先 马丽萍.急性冠脉综合征患者提前停服替格瑞洛现象的研究进展[J].心血管病学进展,2020,(11):1120.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
Acute Coronary Syndrome.Premature Ticagrelor Discontinuation in Patients with[J].Advances in Cardiovascular Diseases,2020,(9):1120.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[8]冯洁渊 .中性粒细胞/淋巴细胞比值和血小板/淋巴细胞比值与急性冠脉综合征的关系研究进展[J].心血管病学进展,2020,(12):1276.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.013]
FENG Jieyuan.The Relationship Between Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio and Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2020,(9):1276.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.013]
[9]魏倩 梁岩.高敏心肌肌钙蛋白在急性冠脉综合征患者中的临床应用进展[J].心血管病学进展,2021,(5):396.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.003]
[10]朱志伦 田乃亮.急性冠脉综合征患者抗血小板降阶治疗方案研究进展[J].心血管病学进展,2021,(6):534.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.014]
ZHU Zhilun,TIAN Nailiang.Advances in De-Escalation of Anti-Platelet Therapy in Patients with Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2021,(9):534.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.014]